Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2004 17:14 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Appoints John H. Dillon II to Board of Directors

HOUSTON, Nov. 18, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (NASDAQ:ENCY) today announced the appointment of John H. Dillon II to its Board of Directors. Mr. Dillon's appointment brings the number...
November 11, 2004 07:01 ET | Source: Encysive Pharmaceuticals Inc.

FDA Grants Encysive Orphan Drug Designation For Thelin

HOUSTON, Nov. 11, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (NASDAQ:ENCY) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Thelin(tm)...
November 09, 2004 16:10 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation and Webcast at 5th Annual SG Cowen Global Health Care Conference

HOUSTON, Nov. 9, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and CEO, will give a corporate overview at SG Cowen's 5th Annual...
October 25, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference

HOUSTON, Oct. 25, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Stephen L. Mueller, Vice President of Finance and Administration, will give a corporate overview at...
September 21, 2004 11:31 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation/Webcast at UBS Global Life Sciences Conference

HOUSTON, Sept. 21, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that it would participate in the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York...
August 02, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Announces Departure of Board Member

HOUSTON, Aug. 2, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that William R. Ringo resigned from the Company's Board of Directors following his appointment as Chief...
July 26, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals to Present at Adams, Harkness & Hill 24th Annual Summer Seminar

HOUSTON, July 26, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and Chief Executive Officer, will give a corporate overview at the...
July 06, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reiterates Guidance for STRIDE-2 Trial Enrollment

HOUSTON, July 6, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today confirmed that enrollment in the STRIDE-2 clinical trial is expected to complete in the third quarter of 2004....
June 23, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Appoints J. Kevin Buchi to Board of Directors

HOUSTON, June 23, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that J. Kevin Buchi, 49, has been elected to the Company's Board of Directors and appointed to serve on...
June 21, 2004 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals to Participate in Punk Ziegel Investor Symposium

HOUSTON, June 21, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and Chief Executive Officer, will participate in the Punk Ziegel...